Table 3 Summary of recommendations
From: Care plans for women pregnant using assisted reproductive technologies: a systematic review
Alexander [23] | ACOG [25] | ASRM [24] | Bates [27] | Chan [26] | Chitayat [19] | Gameiro [21] | Okun [18] | RANZCOG [22] | Thorn [20] | |
|---|---|---|---|---|---|---|---|---|---|---|
Models of care | ||||||||||
 Level of care recommended | ✓ | |||||||||
Risks of ART | ||||||||||
 Multi-fetal reduction options | ✓ | |||||||||
Surveillance, screening and diagnostic testing in pregnancy | ||||||||||
 Closer surveillance | ✓ | |||||||||
 U/S screening for congenital abnormalities | ✓ | ✓ | ||||||||
 Diagnostic testing for IVF-ICSI | ✓ | ✓ | ||||||||
 Labs should be aware of ART pregnancy | ✓ | |||||||||
Treating conditions during pregnancy | ||||||||||
 Treatment for VTE | ✓ | ✓ | ||||||||
 Treatment for thyroid disease | ✓ | ✓ | ||||||||
Psychosocial care and counselling | ||||||||||
 When individuals should be referred or offered counselling | ✓ | ✓ | ||||||||